ArticleJournal of hepatology2015
Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesity.
Article in Journal of hepatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids.The Journal of clinical endocrinology and metabolism · 2015Trial
- Postbiotic Impact on Host Metabolism and Immunity Provides Therapeutic Potential in Metabolic Disease.Endocrine reviews · 2025Review
- Effects of therapeutically approved individual bile acids on the development of metabolic dysfunction-associated steatohepatitis a low bile acid mouse model.Toxicological sciences : an official journal of the Society of Toxicology · 2024Article
- Ceramides are fuel gauges on the drive to cardiometabolic disease.Physiological reviews · 2024Review
- Multispecies probiotics complex improves bile acids and gut microbiota metabolism status in anFrontiers in microbiology · 2024Article
- The supplementation of the multi-strain probiotics WHHPRO™ alleviates high-fat diet-induced metabolic symptoms in rats via gut-liver axis.Frontiers in nutrition · 2023Article
- Tissue-wide metabolomics reveals wide impact of gut microbiota on mice metabolite composition.Scientific reports · 2022Article
- Host-microbial interactions in metabolic diseases: from diet to immunity.Journal of microbiology (Seoul, Korea) · 2022Review
- Impact of Primary and Secondary Bile Acids onPolish journal of microbiology · 2022Review
- Farnesoid X receptor and fibroblast growth factor 15/19 as pharmacological targets.Liver research (Beijing, China) · 2021Review
- Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids HomeostasisFrontiers in pharmacology · 2020Article
- The association between gut microbiota development and maturation of intestinal bile acid metabolism in the first 3 y of healthy Japanese infants.Gut microbes · 2020Article
- Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters.Acta pharmaceutica Sinica. B · 2019Article
- Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models.Pharmacology research & perspectives · 2017Article
- Altenusin, a Nonsteroidal Microbial Metabolite, Attenuates Nonalcoholic Fatty Liver Disease by Activating the Farnesoid X Receptor.Molecular pharmacology · 2017Article
- Targeting the Gut Microbiota-FXR Signaling Axis for Glycemic Control: Does a Dietary Supplement Work Magic?Diabetes · 2017Article
- Recent advances in understanding bile acid homeostasis.F1000Research · 2017Review
- An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.Gastroenterology · 2016Review
- Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism.mSystemsArticle
Corrections and comments
- Comment on
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.